Literature DB >> 467780

Melatonin-and serotonin-stimulated release of vasopressin from rat neurohypophysis in vitro.

A Lemay, A Brouillette, F Denizeau, M Lavoie.   

Abstract

In order to study the control of vasopressin-release, the effect of a series of potential agents was studied in an in vitro perifusion system of rat neurohypophysis after in vivo treatment with nialamide, a monoamine oxidase inhibitor. In this system, metlatonin stimulated vasopressin-release in a dose-dependent manner (1 x 10-8 to 1 x 10-3 M). Serotonin (1 x 10-3 M) also led to a significant increase of vasopressin-release whereas quipazine (1 x 10-3 M), a putative serotonin agonist and monoamine oxidase inhibitor, caused a 3-fold stimulation of the release of the neurohormone. The stimulatory effects of melatonin and serotonin were prevented by omission of Ca2+ combined to an excess of Mg2+ (12mM) in the perifusion medium. 1 x 10-6 M somatostatin did not affect basal or melatonin-stimulated vasopressin-release. These results show that melatonin and serotonin can have a direct stimulatory effect on vasopressin release at the neurohypophyseal level.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 467780     DOI: 10.1016/0303-7207(79)90103-5

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  1 in total

1.  Social isolation rearing-induced anxiety and response to agomelatine in male and female rats: Role of corticosterone, oxytocin, and vasopressin.

Authors:  Brian H Harvey; Wilmie Regenass; Walter Dreyer; Marisa Möller
Journal:  J Psychopharmacol       Date:  2019-02-21       Impact factor: 4.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.